Rchr
J-GLOBAL ID:201301074358722380   Update date: Oct. 02, 2024

MASANORI SASAKI

ササキ マサノリ | MASANORI SASAKI
Affiliation and department:
Homepage URL  (1): http://kaken.nii.ac.jp/d/r/20538136.ja.html
Research field  (1): Neurosurgery
Research theme for competitive and other funds  (55):
  • 2024 - 2027 慢性期脳梗塞に対する骨髄幹細胞治療における至適リハビリ条件の探索
  • 2023 - 2026 Intravenous infusion of exosome for the treatment of neonatal hypoxic ischemic encephalopathy
  • 2023 - 2026 Bone marrow mesenchymal stem cell transplantation prevents concurrent progression of chronic kidney disease and associated cerebrovascular disease
  • 2024 - 2025 Therapeutic strategies for cerebral infarction and spinal cord injury by activating plasticity throughout the central nervous system
  • 2022 - 2025 健康寿命延長に関与する骨髄幹細胞の自己治癒能と全身の恒常性維持
Show all
Papers (96):
  • Tomohiro Yamaki, Shinichi Oka, Satoshi Iyama, Masanori Sasaki, Rie Onodera, Yuko Kataoka-Sasaki, Takahiro Namioka, Ai Namioka, Masahito Nakazaki, Mitsuhiro Takemura, et al. Intravenous infusion of auto-serum-expanded autologous mesenchymal stem cells into chronic severe brain injury patients. Interdisciplinary Neurosurgery. 2024. 36. 101927-101927
  • Tatsuro Yamashita, Masanori Sasaki, Yuichi Sasaki, Hiroshi Nagahama, Shinichi Oka, Yuko Kataoka-Sasaki, Ryo Ukai, Takahiro Yokoyama, Masato Kobayashi, Masafumi Kakizawa, et al. Rehabilitation facilitates functional improvement following intravenous infusion of mesenchymal stem cells in the chronic phase of cerebral ischemia in rats. Brain research. 2024. 1825. 148709-148709
  • Takumi Hoshimaru, Naosuke Nonoguchi, Takuya Kosaka, Motomasa Furuse, Shinji Kawabata, Ryokichi Yagi, Yoshitaka Kurisu, Hideki Kashiwagi, Masahiro Kameda, Toshihiro Takami, et al. Actin Alpha 2, Smooth Muscle (ACTA2) Is Involved in the Migratory Potential of Malignant Gliomas, and Its Increased Expression at Recurrence Is a Significant Adverse Prognostic Factor. Brain sciences. 2023. 13. 10
  • Kota Kurihara, Masanori Sasaki, Hiroshi Nagahama, Hisashi Obara, Ryunosuke Fukushi, Ryosuke Hirota, Mitsunori Yoshimoto, Atsushi Teramoto, Jeffery D Kocsis, Toshihiko Yamashita, et al. Repeated intravenous infusion of mesenchymal stem cells enhances recovery of motor function in a rat model with chronic spinal cord injury. Brain research. 2023. 1817. 148484-148484
  • Ryosuke Hirota, Masanori Sasaki, Osamu Honmou, Toshihiko Yamashita. Mesenchymal Stem Cell Transplantation for Spinal Cord Injury: Current Status and Prospects. Spine Surgery and Related Research. 2023. 7. 4. 319-326
more...
MISC (53):
  • 廣田 亮介, 佐々木 祐典, 本望 修, 山下 敏彦. 特集 脊損患者への投与が始まった脊髄再生医療-脊髄損傷患者に希望が見えるか 亜急性期,慢性期脊髄損傷に対する骨髄間葉系幹細胞移植の現状. 臨床整形外科. 2024. 59. 8. 989-993
  • 廣田 亮介, 佐々木 祐典, 本望 修, 山下 敏彦. 骨髄間葉系幹細胞を用いた脊髄損傷治療の基礎と臨床. 臨床整形外科. 2024. 59. 3. 308-311
  • 福士 龍之介, 佐々木 雄一, 佐々木 祐典, 本望 修, 山下 敏彦. 脊髄損傷に対する再生医療とリハビリテーション-Regenerative medicine and rehabilitation for spinal cord injury-脊椎脊髄疾患に対するリハビリテーション : Now and the Future. Journal of clinical rehabilitation. 2023. 32. 13. 1318-1325
  • 廣田 亮介, 佐々木 祐典, 本望 修, 山下 敏彦. 特集 脊髄損傷の治療アップデート 亜急性期脊髄損傷に対する骨髄間葉系幹細胞移植医療の現状と展望. 関節外科 基礎と臨床. 2022. 41. 3. 244-249
  • 佐々木 祐典, 廣田 亮介, 栗原 康太, 福士 龍之介, 押切 勉, 本望 修, 山下 敏彦. 脊髄損傷などの神経疾患に対する骨髄間葉系幹細胞の経静脈的投与による治療メカニズム-Therapeutic mechanism of intravenous infusion of mesenchymal stem cells for neural diseases including spinal cord injury. 日本整形外科学会雑誌 = The journal of the Japanese Orthopaedic Association. 2021. 95. 12. 1161-1171
more...
Work history (4):
  • 2023/11 - 現在 Sapporo Medical University
  • 2020/04 - 2023/10 Sapporo Medical University Research Institute for Frontier Medicine
  • 2012/08 - 2020/03 Sapporo Medical University Research Institute for Frontier Medicine
  • 2012/01 - 2012/07 Sapporo Medical University Research Institute for Frontier Medicine
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page